Automated mapping and N-Staging of thoracic lymph nodes in contrast-enhanced CT scans of the chest using a fully convolutional neural network.


Journal

European journal of radiology
ISSN: 1872-7727
Titre abrégé: Eur J Radiol
Pays: Ireland
ID NLM: 8106411

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 25 01 2021
revised: 29 03 2021
accepted: 11 04 2021
pubmed: 8 5 2021
medline: 19 5 2021
entrez: 7 5 2021
Statut: ppublish

Résumé

To develop a deep-learning (DL)-based approach for thoracic lymph node (LN) mapping based on their anatomical location. The training-and validation-dataset included 89 contrast-enhanced computed tomography (CT) scans of the chest. 4201 LNs were semi-automatically segmented and then assigned to LN levels according to their anatomical location. The LN level classification task was addressed by a multi-class segmentation procedure using a fully convolutional neural network. Mapping was performed by firstly determining potential level affiliation for each voxel and then performing majority voting over all voxels belonging to each LN. Mean classification accuracies on the validation data were calculated separately for each level and overall Top-1, Top-2 and Top-3 scores were determined, where a Top-X score describes how often the annotated class was within the top-X predictions. To demonstrate the clinical applicability of our model, we tested its N-staging capabilities in a simulated clinical use case scenario assuming a patient diseased with lung cancer. The artificial intelligence(AI)-based assignment revealed mean classification accuracies of 86.36 % (Top-1), 94.48 % (Top-2) and 96.10 % (Top-3). Best accuracies were achieved for LNs in the subcarinal level 7 (98.31 %) and axillary region (98.74 %). The highest misclassification rates were observed among LNs in adjacent levels. The proof-of-principle application in a simulated clinical use case scenario for automated tumor N-staging showed a mean classification accuracy of up to 96.14 % (Top-1). The proposed AI approach for automatic classification of LN levels in chest CT as well as the proof-of-principle-experiment for automatic N-staging, revealed promising results, warranting large-scale validation for clinical application.

Identifiants

pubmed: 33962109
pii: S0720-048X(21)00198-4
doi: 10.1016/j.ejrad.2021.109718
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109718

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Andra-Iza Iuga (AI)

Institute for Diagnostic and Interventional Radiology, University Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany. Electronic address: andra.iuga@uk-koeln.de.

Tanja Lossau (T)

Philips Research Hamburg, Hamburg, Germany.

Liliana Laurenco Caldeira (LL)

Institute for Diagnostic and Interventional Radiology, University Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany.

Miriam Rinneburger (M)

Institute for Diagnostic and Interventional Radiology, University Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany.

Simon Lennartz (S)

Institute for Diagnostic and Interventional Radiology, University Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany.

Nils Große Hokamp (N)

Institute for Diagnostic and Interventional Radiology, University Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany.

Michael Püsken (M)

Institute for Diagnostic and Interventional Radiology, University Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany.

Heike Carolus (H)

Philips Research Hamburg, Hamburg, Germany.

David Maintz (D)

Institute for Diagnostic and Interventional Radiology, University Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany.

Tobias Klinder (T)

Philips Research Hamburg, Hamburg, Germany.

Thorsten Persigehl (T)

Institute for Diagnostic and Interventional Radiology, University Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH